The pull-down assay showed that circ-ZFR was enriched in the AGO2 pellet compared with those in the input control (Supplementary Figure 3), suggesting circ-ZFR also bind to AGO2 to regulate microRNA levels in tumor cells. The gene discussed is AGO2; the disease is neoplasm.